Loading...

Takako Tabata

Title(s)Professional Researcher, Cell and Tissue Biology
SchoolSchool of Dentistry
Phone415-476-8245
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Fetal Zika virus Infection: Role of the human placenta
    NIH/NIAID R21 AI29508Nov 18, 2016 - Oct 31, 2018
    Role: Co-Invesgator
    Persistent human cytomegalovirus infection of the amnion in preterm birth and intrauterine growth restriction
    UCSF the California Preterm Birth Initiative (PTBi-CA)7028222 7028222Jul 1, 2016 - Jun 30, 2018
    Role: Principal Investigator
    HCMV Infection of human placental trophoblast and hematopoietic progenitors
    NIH/NIAID R56 AI105070-01Dec 1, 2012 - Jun 30, 2014
    Role: Co-Investigator
    Fetal CMV Infection: Role of the human placenta; ZIKV supplement
    NIH/NIAID R01 AI046657-16Oct 1, 2012 - Sep 30, 2019
    Role: Co-Investigator
    The role of CEACAM1 in CMV pathogenesis in the human placenta
    NIH/NICHD R21HD061890Jan 1, 2011 - Jun 30, 2013
    Role: Principal Investigator
    CMV Transmission and Replication in Human Placental Villi Implants in SCIDhu Mice
    NIH/NIAID AR21 I090200-02Jul 1, 2010 - Jun 30, 2012
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Tabata T, Petitt M, Fang-Hoover J, Freed DC, Li F, An Z, Wang D, Fu TM, Pereira L. Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas. Vaccines (Basel). 2019 Sep 29; 7(4). PMID: 31569508.
      View in: PubMed
    2. Puerta-Guardo H, Tabata T, Petitt M, Dimitrova M, Glasner DR, Pereira L, Harris E. Zika Virus Non-Structural Protein 1 Disrupts Glycosaminoglycans and Causes Permeability in Developing Human Placentas. J Infect Dis. 2019 Jun 27. PMID: 31250000.
      View in: PubMed
    3. Tabata T, Petitt M, Fang-Hoover J, Pereira L. Survey of cellular immune responses to human cytomegalovirus infection in the microenvironment of the uterine-placental interface. Med Microbiol Immunol. 2019 Aug; 208(3-4):475-485. PMID: 31065796.
      View in: PubMed
    4. Tabata T, Petitt M, Fang-Hoover J and Pereira L.Survey of cellular immune responses to HCMV infection in the microenvironment of the uterine-placental interface (in press). Med Microbiol Immunol. 2019.
    5. Puerta-Guardo, H., Tabata, T., Petitt, M., Dimitrova, , Glasner, D., Pereira, L. and Harris, E.Zika virus non-structural protein 1 disrupts glycosaminoglycans causes permeability in developing human placentas (in press). J Infect Dis. 2019.
    6. Tabata T, Petitt M, Puerta-Guardo H, Michlmayr D, Harris E, Pereira L. Zika Virus Replicates in Proliferating Cells in Explants From First-Trimester Human Placentas, Potential Sites for Dissemination of Infection. J Infect Dis. 2018 03 28; 217(8):1202-1213. PMID: 29106643.
      View in: PubMed
    7. Petitt M, Tabata T, Puerta-Guardo H, Harris E, Pereira L. Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo. Curr Opin Virol. 2017 12; 27:48-56. PMID: 29172071.
      View in: PubMed
    8. Pereira L, Tabata T, Petitt M, Fang-Hoover J. Congenital cytomegalovirus infection undermines early development and functions of the human placenta. Placenta. 2017 Nov; 59 Suppl 1:S8-S16. PMID: 28477968.
      View in: PubMed
    9. Tabata T, Petitt M, Fang-Hoover J, Zydek M, Pereira L. Persistent Cytomegalovirus Infection in Amniotic Membranes of the Human Placenta. Am J Pathol. 2016 11; 186(11):2970-2986. PMID: 27638253.
      View in: PubMed
    10. Tabata T, Petitt M, Puerta-Guardo H, Michlmayr D, Wang C, Fang-Hoover J, Harris E, Pereira L. Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission. Cell Host Microbe. 2016 Aug 10; 20(2):155-66. PMID: 27443522.
      View in: PubMed
    11. Tabata T, Petitt M, Zydek M, Fang-Hoover J, Larocque N, Tsuge M, Gormley M, Kauvar LM, Pereira L. Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta. J Virol. 2015 May; 89(9):5134-47. PMID: 25741001.
      View in: PubMed
    12. Pereira, L., Tabata, T. and Petitt, M.Cytomegalovirus infection and pathogenesis in the human placenta. Microbiology Australia. 2015.
    13. Kauvar LM, Liu K, Park M, DeChene N, Stephenson R, Tenorio E, Ellsworth SL, Tabata T, Petitt M, Tsuge M, Fang-Hoover J, Adler SP, Cui X, McVoy MA, Pereira L. A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types. Antimicrob Agents Chemother. 2015 Mar; 59(3):1558-68. PMID: 25534746.
      View in: PubMed
    14. Zydek M, Petitt M, Fang-Hoover J, Adler B, Kauvar LM, Pereira L, Tabata T. HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex. Viruses. 2014 Mar 19; 6(3):1346-64. PMID: 24651029.
      View in: PubMed
    15. Pereira L, Petitt M, Fong A, Tsuge M, Tabata T, Fang-Hoover J, Maidji E, Zydek M, Zhou Y, Inoue N, Loghavi S, Pepkowitz S, Kauvar LM, Ogunyemi D. Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis. 2014 May 15; 209(10):1573-84. PMID: 24403553.
      View in: PubMed
    16. Pereira L, Petitt M, Tabata T. Cytomegalovirus infection and antibody protection of the developing placenta. Clin Infect Dis. 2013 Dec; 57 Suppl 4:S174-7. PMID: 24257421.
      View in: PubMed
    17. Pereira L., Tabata T., Petitt M. and Fang-Hoover, J.Cytomegaloviruses: From Molecular Pathogenesis to Therapy 2012. 2013; 73-86.
    18. Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, Shiboski S, Inoue N, Pereira L. Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. Am J Pathol. 2012 Nov; 181(5):1540-59. PMID: 22959908.
      View in: PubMed
    19. Maidji E, Nigro G, Tabata T, McDonagh S, Nozawa N, Shiboski S, Muci S, Anceschi MM, Aziz N, Adler SP, Pereira L. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol. 2010 Sep; 177(3):1298-310. PMID: 20651234.
      View in: PubMed
    20. Nozawa N, Fang-Hoover J, Tabata T, Maidji E, Pereira L. Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. J Clin Virol. 2009 Dec; 46 Suppl 4:S58-63. PMID: 19854676.
      View in: PubMed
    21. Tabata T, Kawakatsu H, Maidji E, Sakai T, Sakai K, Fang-Hoover J, Aiba M, Sheppard D, Pereira L. Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production. Am J Pathol. 2008 Apr; 172(4):1127-40. PMID: 18349127.
      View in: PubMed
    22. Pereira L, Maidji E, Fisher SJ, McDonagh S, Tabata T.. HCMV persistence in the population: potential transplacental transmission. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 2007; 814-830.
    23. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol. 2006 Apr; 168(4):1210-26. PMID: 16565496.
      View in: PubMed
    24. Pereira L, Maidji E, McDonagh S, Tabata T. Insights into viral transmission at the uterine-placental interface. Trends Microbiol. 2005 Apr; 13(4):164-74. PMID: 15817386.
      View in: PubMed
    25. Pereira L., Tabata T., Petitt M. and Fang-Hoover, J.Routes of human cytomegalovirus transmission and infection at the uterine-placental interface. Cytomegalovirus: Pathogenesis, Molecular Biology and Infection Control. 2005; 29-48.
    26. Wright A, Zhou Y, Weier JF, Caceres E, Kapidzic M, Tabata T, Kahn M, Nash C, Fisher SJ. Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway. Am J Med Genet A. 2004 Nov 01; 130A(4):354-64. PMID: 15389712.
      View in: PubMed
    27. Yamamoto-Tabata T, McDonagh S, Chang HT, Fisher S, Pereira L. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol. 2004 Mar; 78(6):2831-40. PMID: 14990702.
      View in: PubMed
    28. Kanai K, Kuwabara S, Mori M, Arai K, Yamamoto T, Hattori T. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle Nerve. 2003 Jan; 27(1):113-6. PMID: 12508305.
      View in: PubMed
    29. Yamamoto T, Nakamura Y. A single tube PCR assay for simultaneous amplification of HSV-1/-2, VZV, CMV, HHV-6A/-6B, and EBV DNAs in cerebrospinal fluid from patients with virus-related neurological diseases. J Neurovirol. 2000 Oct; 6(5):410-7. PMID: 11031694.
      View in: PubMed
    30. Yamaguchi M, Yamamoto T, Tate G, Matsumoto T, Matsumiya A, Kuzume M, Sanada Y, Kumada K. Specific detection of epstein-barr virus in inflammatory pseudotumor of the spleen in a patient with a high serum level of soluble IL-2 receptor. J Gastroenterol. 2000; 35(7):563-6. PMID: 10905367.
      View in: PubMed
    31. Yamamoto T, Nakamura Y, Kishimoto K, Takeuchi H, Shirakata M, Mitsuya T, Hirai K. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1. Virus Res. 1999 Dec 01; 65(1):43-55. PMID: 10564752.
      View in: PubMed
    32. Li J, Yamamoto T, Ohtsubo K, Shirakata M, Hirai K. Major product pp43 of human cytomegalovirus U(L)112-113 gene is a transcriptional coactivator with two functionally distinct domains. Virology. 1999 Jul 20; 260(1):89-97. PMID: 10405360.
      View in: PubMed
    33. Suzuki K, Jimi T, Wakayama Y, Yamamoto T, Nakamura R. [A case of non-herpetic acute encephalitis presenting high intensity lesion at unilateral temparal cortex on MR FLAIR image]. Rinsho Shinkeigaku. 1999 Jul; 39(7):750-6. PMID: 10548915.
      View in: PubMed
    34. Yuki N, Yamamoto T, Hirata K. Correlation between cytomegalovirus infection and IgM anti-MAG/SGPG antibody-associated neuropathy. Ann Neurol. 1998 Sep; 44(3):408-10. PMID: 9749612.
      View in: PubMed
    35. Yamamoto T, Suzuki S, Radsak K, Hirai K. The UL112/113 gene products of human cytomegalovirus which colocalize with viral DNA in infected cell nuclei are related to efficient viral DNA replication. Virus Res. 1998 Jul; 56(1):107-14. PMID: 9784069.
      View in: PubMed
    36. Yamamoto, T, Nakamura, Y. and Hirai, K.[Molecular diagnosis of HCMV infection]. Nippon Rinsho. 1998; 56:121-28.
    37. Yamamoto, T. and Hirai, K.[Molecular pathological studies on Epstein-Barr Virus (EBV) infected cells and EBV-associated tumor cells]. Nippon Rinsho. 1998; 55:452-60.
    38. Hirai, K., Yamamoto, T., Hironaka, T., Arai, T., Takeuchi, H., Kobayashi, R., Hojo, I., and Oishi, T.Epstein-Barr virus genome in infected cells and cancer. Gann Monograph on Cancer Research . 1998; 45:29-39.
    39. Hirai, K and Yamamoto, T.[Methods and application of in situ PCR]. Kidney and Dialysis. 1998; Supplement:99-105.
    40. Takeda A, Masuda Y, Yamamoto T, Hirabayashi T, Nakamura Y, Nakaya K. Cloning and analysis of cDNA encoding rat bleomycin hydrolase, a DNA-binding cysteine protease. J Biochem. 1996 Aug; 120(2):353-9. PMID: 8889821.
      View in: PubMed
    41. Takeuchi, T., Takeuchi, H., Li, K., Shinohara, H., Yamamoto, T., Fujii, H., Morisita, K., Fukuhara, M., and Hirai, K.[The observation of time-course cytopathologic changes in human embryo lung fibroblast cells infected with human cytomegalovirus]. J Jpn Soc Clin Cytol. 1996; 35:26-31.
    42. Nakamura Y, Takai Y, Shimada S, Nakamura H, Tokoro A, Yamamoto T.[Epidemiological analysis of Epstein-Barr virus infection]. Rinsho Byori. 1996; 44:659-64.
    43. Imai, K., Yamamoto, T., Ito, S., Yoshida, K., Maeda, H., Kajiwara, M., Takagi, .S, Okawa, H., Hirai, K., and Yata, J.[Epstein-Barr virus-associated lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome after bone marrow transplantation]. Jpn J Pediatr Hematol. 1996; 10:210-5.
    44. Takeda A, Higuchi D, Yamamoto T, Nakamura Y, Masuda Y, Hirabayashi T, Nakaya K. Purification and characterization of bleomycin hydrolase, which represents a new family of cysteine proteases, from rat skin. J Biochem. 1996 Jan; 119(1):29-36. PMID: 8907172.
      View in: PubMed
    45. Takeda A, Yamamoto T, Nakamura Y, Takahashi T, Hibino T. Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L. FEBS Lett. 1995 Feb 06; 359(1):78-80. PMID: 7851535.
      View in: PubMed
    46. Yamamoto T, Nakajima Y, Hironaka T, Hirai K, Nakamura Y. Rapid detection of cytomegalovirus DNA in sera using the polymerase chain reaction: relationship with clinical diagnosis of cytomegalovirus infection after renal transplantation. Nephron. 1995; 70(1):100-3. PMID: 7617086.
      View in: PubMed
    47. Yamamoto, T., Ohtsubo, K., Suzuki, S., Takeda, A., and Hirai, K.Characterization of the UL112/113 gene, essential for human cytomegalovirus DNA replication. Scand J Infect Dis. 1995; Suppl:7.
    48. Yamamoto T, Nakajima Y, Yamamoto M, Hironaka T, Hirai K, Nakamura Y. Epstein-Barr virus activity in patients on chronic hemodialysis. Nephron. 1995; 70(4):449-54. PMID: 7477651.
      View in: PubMed
    49. Iwayama S, Yamamoto T, Furuya T, Kobayashi R, Ikuta K, Hirai K. Intracellular localization and DNA-binding activity of a class of viral early phosphoproteins in human fibroblasts infected with human cytomegalovirus (Towne strain). J Gen Virol. 1994 Dec; 75 ( Pt 12):3309-18. PMID: 7996125.
      View in: PubMed
    50. Takeda, A, Yamamoto, T, Iwasawa, A, Nakamura, Y, Higuchi, D, Takahashi, T, and Hibino, T.A biological of squamous cell carcinoma antigen. Proteases Involved in Cancer. 1994; 161-165.
    51. Yamamoto T, Nakajima Y, Hironaka T, Hirai K, Nakamura Y.[Rapid diagnosis of cytomegalovirus (CMV) infection in a renal transplant recipient by polymerase chain reaction (PCR)]. Rinsho Byori. 1994; 42:966-70.
    52. Hirai, K, Hironaka, T, and Yamamoto, T.Structure and expression of standard Epstein-Barr virus DNA in P3HR-1 subclone containing a single viral genome equivalent per cell. The Epstein-Barr Virus Associated Diseases. 1993; 225:289-94.
    53. Yamamoto, T., Yoshida, K., Torasawa, K., Tada, H., and Nakamura.[Epidemiological analysis of infectious mononucleosis as primary Epstein-Barr virus infection]. Rinsho Byori. 1992; 40:1210-16.
    54. Yamamoto M, Tabata T, Smith M, Tanaka A, Nonoyama M. Cycloheximide-resistant gene of Epstein-Barr virus in freshly infected B lymphocytes. Virology. 1989 May; 170(1):307-10. PMID: 2541549.
      View in: PubMed
    55. Sawada K, Yamamoto M, Tabata T, Smith M, Tanaka A, Nonoyama M. Expression of EBNA-3 family in fresh B lymphocytes infected with Epstein-Barr virus. Virology. 1989 Jan; 168(1):22-30. PMID: 2535905.
      View in: PubMed
    56. Nonoyama M, Wen LT, Tabata T, Tanaka A. A novel EBNA-1 titration method and putative anti-EBNA-1 protein. J Virol Methods. 1988 Sep; 21(1-4):161-70. PMID: 2846610.
      View in: PubMed
    57. Sakamoto K, Tabata T, Shirasaki K, Inagaki T, Nakayama S. Effects of gamma-oryzanol and cycloartenol ferulic acid ester on cholesterol diet induced hyperlipidemia in rats. Jpn J Pharmacol. 1987 Dec; 45(4):559-65. PMID: 3444123.
      View in: PubMed